HealthLynked Corp Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
HealthLynked Corp quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2024.
  • HealthLynked Corp Operating Income (Loss) for the quarter ending September 30, 2024 was -$1.67M, a 41.1% decline year-over-year.
  • HealthLynked Corp Operating Income (Loss) for the twelve months ending September 30, 2024 was -$5.04M, a 29.9% increase year-over-year.
  • HealthLynked Corp annual Operating Income (Loss) for 2023 was -$4.15M, a 52.1% increase from 2022.
  • HealthLynked Corp annual Operating Income (Loss) for 2022 was -$8.66M, a 62.4% decline from 2021.
  • HealthLynked Corp annual Operating Income (Loss) for 2021 was -$5.33M, a 73.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$5.04M -$1.67M -$487K -41.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$4.55M -$1.08M -$281K -35.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$4.27M -$1.18M -$121K -11.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$4.15M -$1.11M +$3.04M +73.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$7.19M -$1.18M +$347K +22.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$7.54M -$798K +$729K +47.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$8.26M -$1.06M +$395K +27.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$8.66M -$4.15M -$2.29M -123% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$6.37M -$1.53M -$1.04M -212% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$5.33M -$1.53M -$112K -7.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$5.21M -$1.45M +$117K +7.44% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$5.33M -$1.86M -$807K -76.8% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$4.52M -$490K +$353K +41.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$4.88M -$1.41M -$765K -118% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$4.11M -$1.57M -$1.04M -197% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$3.07M -$1.05M -$179K -20.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$2.89M -$843K -$27.4K -3.36% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.87M -$650K +$48.2K +6.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.91M -$528K +$296K +35.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$3.21M -$872K +$27.4K +3.04% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$3.24M -$816K +$151K +15.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$3.39M -$698K -$87.8K -14.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$3.3M -$823K -$327K -66% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$2.97M -$899K -$490K -120% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$2.48M -$966K -$454K -88.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$2.03M -$610K -$128K -26.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$1.9M -$496K -$109K -28% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.79M -$409K -$17.9K -4.57% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 -$1.77M -$512K -$59.5K -13.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.71M -$483K -$299K -163% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$1.41M -$387K -$240K -163% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$1.17M -$391K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$453K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$183K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$147K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.